Avingtrans PLC
28 July 2026
28 July 2026
Avingtrans Plc
("Avingtrans", the "Company", or the "Group")
PDMR Dealings
Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces that on 28 July 2026, the Company was notified of the exercise of 439,600 options over ordinary shares of 5p each in the Company ("Ordinary Shares") by Steve McQuillan, Chief Executive Officer, Stephen King, Chief Financial Officer and Austen Adams, Chief Operating Officer.
On the same date, the same three PDMRs sold, in aggregate, 397,500 Ordinary Shares at 710 pence per Ordinary Share. The following table summarises the dealings and resultant shareholdings of the three PDMRs:
|
PDMR |
Role |
Options exercised |
Options sold |
Increase in shareholding |
Beneficial interest in Ordinary Shares following the transactions |
Resulting percentage holding of total voting rights held |
|
Steve McQuillan |
Chief Executive Officer |
180,000 |
157,500 |
22,500 |
851,175 |
2.28% |
|
Stephen King |
Chief Financial Officer |
149,600 |
140,000 |
9,600 |
698,214 |
1.87% |
|
Austen Adams |
Chief Operating Officer |
110,000 |
100,000 |
10,000 |
183,301 |
0.49% |
Issue of Equity
Application has been made for the admission to trading on AIM for the 439,600 new Ordinary Shares ("Admission"). It is expected that Admission will become effective on 3 August 2026.
Total Voting Rights
Following the issue of the 439,600 new Ordinary Shares, the Company will have a total of 37,370,672 Ordinary Shares in issue. The Company does not hold any shares in Treasury.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The above information is provided by the Company in accordance with its obligations under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
|
Avingtrans plc |
01354 692 391 |
|
Roger McDowell, Chairman Steve McQuillan, Chief Executive Officer Stephen King, Chief Financial Officer |
|
|
Singer Capital Markets (Nominated Adviser and Broker) |
020 7496 3000 |
|
Shaun Dobson |
|
|
Alex Bond Daniel Ingram |
|
|
Carl Diebitsch |
|
|
IFC Advisory (Financial PR) |
020 3934 6630 |
|
Graham Herring Tim Metcalfe Zach Cohen |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||||||||||||||
|
a) |
Name |
1. Steve McQuillan 2. Stephen King 3. Austen Adams |
|||||||||||||||
|
2 |
Reason for the notification |
||||||||||||||||
|
a) |
Position/status |
1. Chief Executive Officer 2. Chief Financial Officer 3. Chief Operating Officer |
|||||||||||||||
|
|
Initial notification /Amendment |
Initial notification |
|||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||||||||
|
a) |
Name |
Avingtrans PLC |
|||||||||||||||
|
b)
|
LEI |
213800ZZ96CKPI423E86 |
|||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary Shares of 5p each |
|||||||||||||||
|
Identification code |
ISIN: GB0009188797 |
||||||||||||||||
|
b)
|
Nature of the transaction |
Exercise of options pursuant to the CSOP |
|||||||||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||||||||
|
d) |
Aggregated information |
n/a |
|||||||||||||||
|
- Aggregated volume |
|||||||||||||||||
|
- Price |
|||||||||||||||||
|
e) |
Date of the transaction |
28 July 2026 |
|||||||||||||||
|
f) |
Place of the transaction |
Off market |
|||||||||||||||
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
||||||||||||||||
|
a) |
Name |
1. Steve McQuillan 2. Stephen King 3. Austen Adams |
|||||||||||||||
|
2 |
Reason for the notification |
||||||||||||||||
|
a) |
Position/status |
1. Chief Executive Officer 2. Chief Financial Officer 3. Chief Operating Officer |
|||||||||||||||
|
|
Initial notification /Amendment |
Initial notification |
|||||||||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||||||||
|
a) |
Name |
Avingtrans PLC |
|||||||||||||||
|
b)
|
LEI |
213800ZZ96CKPI423E86 |
|||||||||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||||||
|
a) |
Description of the financial instrument, type of instrument |
Ordinary Shares of 5p each |
|||||||||||||||
|
Identification code |
ISIN: GB0009188797 |
||||||||||||||||
|
b)
|
Nature of the transaction |
Sales of Ordinary Shares |
|||||||||||||||
|
c) |
Price(s) and volume(s) |
|
|||||||||||||||
|
d) |
Aggregated information |
n/a |
|||||||||||||||
|
- Aggregated volume |
|||||||||||||||||
|
- Price |
|||||||||||||||||
|
e) |
Date of the transaction |
28 July 2026 |
|||||||||||||||
|
f) |
Place of the transaction |
London Stock Exchange, AIM |
|||||||||||||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.